Global Blood Irradiation Market Strategic Research Report

Scope of the Report

The global Blood Irradiation market size is predicted to grow from US$ 105 million in 2025 to US$ 132 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.

Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients. It is worth noting that cesium and X-ray irradiators are devices dedicated to blood irradiation, usually operated by specialized institutions or departments external to the healthcare facilities that are actually using the irradiated blood (and thus have to purchase it from the irradiation service providers); in contrast, many user facilities already have LINACs and cobalt sources for cancer therapy and other treatments. These units, although they are designed for other purposes, can be used for blood irradiation on a limited basis. For example, a blood bag holder can be placed where a patient would be exposed and the LINAC operated to irradiate the blood instead of a person.

The primary drivers of the blood irradiation market is the rising prevalence of immune-compromised conditions, such as cancer, organ transplant, and autoimmune diseases. These conditions often require blood transfusions, where blood irradiation can prevent transfusion-associated graft-versus-host disease (TA-GVHD). Additionally, advancements in blood irradiation technology and increased healthcare spending globally are boosting market demand. Regulatory agencies in many regions have also established strict guidelines to ensure the safety of blood transfusions, promoting the adoption of blood irradiation equipment in hospitals and blood banks.

A significant challenge for the blood irradiation market is the high cost associated with irradiation equipment and maintenance. These expenses can be prohibitive for smaller healthcare facilities and blood banks, limiting adoption in low-resource settings. Another challenge is the growing availability of alternative methods for blood sterilization and immunomodulation, which compete with blood irradiation. Regulatory barriers and the need for extensive training and specialized staff for handling irradiation equipment further add to the cost and operational complexity, impacting market growth, particularly in developing countries.

Global Blood Irradiation key players include Best Theratronics, Fujifilm, Gilardoni, Gamma-Service, etc. Global top four manufacturers hold a share about 70%. North America is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent. In terms of product, Gamma-ray Blood Irradiation is the largest segment, with a share over 50%. And in terms of application, the largest application is Blood Bank, followed by Hospital, Research Institutions.

This report presents a comprehensive overview of the global Blood Irradiation market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• X-ray Blood Irradiation
• Gamma-ray Blood Irradiation

Segment by Application

• Blood Bank
• Hospital
• Research Institutions

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Irradiation market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Blood Bank, Hospital, Research Institutions evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact